Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001756770-24-000066
Filing Date
2024-11-07
Accepted
2024-11-06 20:24:16
Documents
7
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 6-K q3246-kcover.htm 6-K 19165
2 EX-99.1 q324-exx992xfsandmda.htm EX-99.1 2566672
3 EX-99.2 q324ceocertification.htm EX-99.2 12398
4 EX-99.3 q324cfocertification.htm EX-99.3 12036
5 EX-99.4 q324earningsrelease.htm EX-99.4 235238
6 curlf-20221231xex99d2001a.jpg GRAPHIC 13984
7 image_0.jpg GRAPHIC 8736
  Complete submission text file 0001756770-24-000066.txt   2878186
Mailing Address 420 LEXINGTON AVENUE NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE NEW YORK NY 10170 781-451-0117
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-249081 | Film No.: 241432734
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)